Diamond Power Infrastructure Limited (DIACABS.BO) Stock Competitors & Peer Comparison
See (DIACABS.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DIACABS.BO | ₹192.75 | +2.25% | 101.6B | 64.25 | ₹3.00 | N/A |
| CUMMINSIND.BO | ₹5,787.70 | +1.76% | 1.6T | 71.38 | ₹81.08 | +0.92% |
| CUMMINSIND.NS | ₹5,787.50 | +1.67% | 1.6T | 68.05 | ₹85.05 | +0.92% |
| ABB.BO | ₹7,160.20 | -0.34% | 1.5T | 85.87 | ₹83.38 | +0.55% |
| ABB.NS | ₹7,156.00 | -0.56% | 1.5T | 97.23 | ₹73.60 | +0.55% |
| BHEL.BO | ₹389.85 | -4.00% | 1.4T | 84.75 | ₹4.60 | +0.13% |
| BHEL.NS | ₹389.20 | -4.21% | 1.4T | 84.61 | ₹4.60 | +0.13% |
| SIEMENS.NS | ₹3,686.90 | -0.61% | 1.3T | 77.62 | ₹47.50 | N/A |
| SIEMENS.BO | ₹3,686.50 | -0.61% | 1.3T | 77.82 | ₹47.37 | N/A |
| THERMAX.NS | ₹4,875.90 | +1.91% | 549.3B | 76.06 | ₹64.11 | +0.29% |
Stock Comparison
DIACABS.BO vs CUMMINSIND.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, CUMMINSIND.BO has a market cap of 1.6T. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while CUMMINSIND.BO trades at ₹5,787.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas CUMMINSIND.BO's P/E ratio is 71.38. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to CUMMINSIND.BO's ROE of +0.30%. Regarding short-term risk, DIACABS.BO is more volatile compared to CUMMINSIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check CUMMINSIND.BO's competition here
DIACABS.BO vs CUMMINSIND.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, CUMMINSIND.NS has a market cap of 1.6T. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while CUMMINSIND.NS trades at ₹5,787.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas CUMMINSIND.NS's P/E ratio is 68.05. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to CUMMINSIND.NS's ROE of +0.30%. Regarding short-term risk, DIACABS.BO is more volatile compared to CUMMINSIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check CUMMINSIND.NS's competition here
DIACABS.BO vs ABB.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ABB.BO has a market cap of 1.5T. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ABB.BO trades at ₹7,160.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ABB.BO's P/E ratio is 85.87. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ABB.BO's ROE of +0.41%. Regarding short-term risk, DIACABS.BO is more volatile compared to ABB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ABB.BO's competition here
DIACABS.BO vs ABB.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ABB.NS has a market cap of 1.5T. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ABB.NS trades at ₹7,156.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ABB.NS's P/E ratio is 97.23. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ABB.NS's ROE of +0.41%. Regarding short-term risk, DIACABS.BO is more volatile compared to ABB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ABB.NS's competition here
DIACABS.BO vs BHEL.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, BHEL.BO has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while BHEL.BO trades at ₹389.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas BHEL.BO's P/E ratio is 84.75. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to BHEL.BO's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is less volatile compared to BHEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check BHEL.BO's competition here
DIACABS.BO vs BHEL.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, BHEL.NS has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while BHEL.NS trades at ₹389.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas BHEL.NS's P/E ratio is 84.61. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to BHEL.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is less volatile compared to BHEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check BHEL.NS's competition here
DIACABS.BO vs SIEMENS.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, SIEMENS.NS has a market cap of 1.3T. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while SIEMENS.NS trades at ₹3,686.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas SIEMENS.NS's P/E ratio is 77.62. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SIEMENS.NS's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is more volatile compared to SIEMENS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SIEMENS.NS's competition here
DIACABS.BO vs SIEMENS.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, SIEMENS.BO has a market cap of 1.3T. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while SIEMENS.BO trades at ₹3,686.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas SIEMENS.BO's P/E ratio is 77.82. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SIEMENS.BO's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is more volatile compared to SIEMENS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SIEMENS.BO's competition here
DIACABS.BO vs THERMAX.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, THERMAX.NS has a market cap of 549.3B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while THERMAX.NS trades at ₹4,875.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas THERMAX.NS's P/E ratio is 76.06. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to THERMAX.NS's ROE of +0.14%. Regarding short-term risk, DIACABS.BO is less volatile compared to THERMAX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check THERMAX.NS's competition here
DIACABS.BO vs THERMAX.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, THERMAX.BO has a market cap of 548.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while THERMAX.BO trades at ₹4,870.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas THERMAX.BO's P/E ratio is 80.64. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to THERMAX.BO's ROE of +0.14%. Regarding short-term risk, DIACABS.BO is less volatile compared to THERMAX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check THERMAX.BO's competition here
DIACABS.BO vs AIAENG.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, AIAENG.NS has a market cap of 428.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while AIAENG.NS trades at ₹4,596.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas AIAENG.NS's P/E ratio is 33.77. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to AIAENG.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to AIAENG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check AIAENG.NS's competition here
DIACABS.BO vs AIAENG.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, AIAENG.BO has a market cap of 428.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while AIAENG.BO trades at ₹4,590.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas AIAENG.BO's P/E ratio is 36.83. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to AIAENG.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to AIAENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check AIAENG.BO's competition here
DIACABS.BO vs VOLTAS.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, VOLTAS.NS has a market cap of 425.7B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while VOLTAS.NS trades at ₹1,286.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas VOLTAS.NS's P/E ratio is 113.85. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to VOLTAS.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is less volatile compared to VOLTAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check VOLTAS.NS's competition here
DIACABS.BO vs VOLTAS.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, VOLTAS.BO has a market cap of 425.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while VOLTAS.BO trades at ₹1,286.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas VOLTAS.BO's P/E ratio is 84.61. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to VOLTAS.BO's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is less volatile compared to VOLTAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check VOLTAS.BO's competition here
DIACABS.BO vs GET&D.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, GET&D.NS has a market cap of 397.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while GET&D.NS trades at ₹1,552.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas GET&D.NS's P/E ratio is 100.73. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GET&D.NS's ROE of +0.27%. Regarding short-term risk, DIACABS.BO is less volatile compared to GET&D.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check GET&D.NS's competition here
DIACABS.BO vs BLUESTARCO.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, BLUESTARCO.NS has a market cap of 330.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while BLUESTARCO.NS trades at ₹1,607.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas BLUESTARCO.NS's P/E ratio is 62.82. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to BLUESTARCO.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is less volatile compared to BLUESTARCO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check BLUESTARCO.NS's competition here
DIACABS.BO vs BLUESTARCO.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, BLUESTARCO.BO has a market cap of 330.2B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while BLUESTARCO.BO trades at ₹1,605.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas BLUESTARCO.BO's P/E ratio is 66.75. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to BLUESTARCO.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is less volatile compared to BLUESTARCO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check BLUESTARCO.BO's competition here
DIACABS.BO vs KIRLOSENG.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KIRLOSENG.BO has a market cap of 283.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KIRLOSENG.BO trades at ₹1,950.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KIRLOSENG.BO's P/E ratio is 49.91. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KIRLOSENG.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is less volatile compared to KIRLOSENG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLOSENG.BO's competition here
DIACABS.BO vs KIRLOSENG.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KIRLOSENG.NS has a market cap of 283.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KIRLOSENG.NS trades at ₹1,949.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KIRLOSENG.NS's P/E ratio is 50.01. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KIRLOSENG.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is less volatile compared to KIRLOSENG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLOSENG.NS's competition here
DIACABS.BO vs MTARTECH.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, MTARTECH.BO has a market cap of 238.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while MTARTECH.BO trades at ₹7,756.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas MTARTECH.BO's P/E ratio is 256.07. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to MTARTECH.BO's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is less volatile compared to MTARTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check MTARTECH.BO's competition here
DIACABS.BO vs MTARTECH.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, MTARTECH.NS has a market cap of 238.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while MTARTECH.NS trades at ₹7,755.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas MTARTECH.NS's P/E ratio is 255.87. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to MTARTECH.NS's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is less volatile compared to MTARTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check MTARTECH.NS's competition here
DIACABS.BO vs TRITURBINE.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, TRITURBINE.NS has a market cap of 220.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while TRITURBINE.NS trades at ₹693.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas TRITURBINE.NS's P/E ratio is 63.21. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TRITURBINE.NS's ROE of +0.27%. Regarding short-term risk, DIACABS.BO is less volatile compared to TRITURBINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check TRITURBINE.NS's competition here
DIACABS.BO vs TRITURBINE.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, TRITURBINE.BO has a market cap of 220.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while TRITURBINE.BO trades at ₹693.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas TRITURBINE.BO's P/E ratio is 62.86. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TRITURBINE.BO's ROE of +0.27%. Regarding short-term risk, DIACABS.BO is less volatile compared to TRITURBINE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check TRITURBINE.BO's competition here
DIACABS.BO vs KAYNES.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KAYNES.BO has a market cap of 213.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KAYNES.BO trades at ₹3,191.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KAYNES.BO's P/E ratio is 58.49. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KAYNES.BO's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to KAYNES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KAYNES.BO's competition here
DIACABS.BO vs KAYNES.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KAYNES.NS has a market cap of 213.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KAYNES.NS trades at ₹3,190.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KAYNES.NS's P/E ratio is 58.74. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KAYNES.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to KAYNES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KAYNES.NS's competition here
DIACABS.BO vs TDPOWERSYS.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, TDPOWERSYS.NS has a market cap of 207.1B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while TDPOWERSYS.NS trades at ₹1,325.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas TDPOWERSYS.NS's P/E ratio is 86.58. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TDPOWERSYS.NS's ROE of +0.25%. Regarding short-term risk, DIACABS.BO is less volatile compared to TDPOWERSYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check TDPOWERSYS.NS's competition here
DIACABS.BO vs TDPOWERSYS.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, TDPOWERSYS.BO has a market cap of 207B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while TDPOWERSYS.BO trades at ₹1,325.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas TDPOWERSYS.BO's P/E ratio is 86.51. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TDPOWERSYS.BO's ROE of +0.25%. Regarding short-term risk, DIACABS.BO is less volatile compared to TDPOWERSYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check TDPOWERSYS.BO's competition here
DIACABS.BO vs ELGIEQUIP.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ELGIEQUIP.BO has a market cap of 196.2B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ELGIEQUIP.BO trades at ₹622.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ELGIEQUIP.BO's P/E ratio is 45.67. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ELGIEQUIP.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is less volatile compared to ELGIEQUIP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check ELGIEQUIP.BO's competition here
DIACABS.BO vs ELGIEQUIP.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ELGIEQUIP.NS has a market cap of 196.1B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ELGIEQUIP.NS trades at ₹622.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ELGIEQUIP.NS's P/E ratio is 45.71. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ELGIEQUIP.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is less volatile compared to ELGIEQUIP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check ELGIEQUIP.NS's competition here
DIACABS.BO vs LAXMIMACH.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, LAXMIMACH.BO has a market cap of 185.2B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while LAXMIMACH.BO trades at ₹17,338.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas LAXMIMACH.BO's P/E ratio is 63.86. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to LAXMIMACH.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to LAXMIMACH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LAXMIMACH.BO's competition here
DIACABS.BO vs LAXMIMACH.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, LAXMIMACH.NS has a market cap of 185.1B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while LAXMIMACH.NS trades at ₹17,324.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas LAXMIMACH.NS's P/E ratio is 63.45. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to LAXMIMACH.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to LAXMIMACH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LAXMIMACH.NS's competition here
DIACABS.BO vs LMW.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, LMW.NS has a market cap of 168.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while LMW.NS trades at ₹15,799.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas LMW.NS's P/E ratio is 129.51. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to LMW.NS's ROE of +0.05%. Regarding short-term risk, DIACABS.BO is more volatile compared to LMW.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LMW.NS's competition here
DIACABS.BO vs LMW.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, LMW.BO has a market cap of 168.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while LMW.BO trades at ₹15,777.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas LMW.BO's P/E ratio is 128.65. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to LMW.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to LMW.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LMW.BO's competition here
DIACABS.BO vs AZAD.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, AZAD.NS has a market cap of 142.1B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while AZAD.NS trades at ₹2,200.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas AZAD.NS's P/E ratio is 107.39. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to AZAD.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is less volatile compared to AZAD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check AZAD.NS's competition here
DIACABS.BO vs TEGA.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, TEGA.NS has a market cap of 140.7B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while TEGA.NS trades at ₹1,872.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas TEGA.NS's P/E ratio is 91.51. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TEGA.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to TEGA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TEGA.NS's competition here
DIACABS.BO vs TEGA.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, TEGA.BO has a market cap of 140.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while TEGA.BO trades at ₹1,871.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas TEGA.BO's P/E ratio is 91.49. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TEGA.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to TEGA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TEGA.BO's competition here
DIACABS.BO vs KSB.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KSB.NS has a market cap of 138.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KSB.NS trades at ₹795.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KSB.NS's P/E ratio is 53.57. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KSB.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is less volatile compared to KSB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check KSB.NS's competition here
DIACABS.BO vs KSB.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KSB.BO has a market cap of 138B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KSB.BO trades at ₹793.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KSB.BO's P/E ratio is 53.31. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KSB.BO's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is less volatile compared to KSB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check KSB.BO's competition here
DIACABS.BO vs INOXINDIA.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, INOXINDIA.NS has a market cap of 136.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while INOXINDIA.NS trades at ₹1,505.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas INOXINDIA.NS's P/E ratio is 53.14. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to INOXINDIA.NS's ROE of +0.27%. Regarding short-term risk, DIACABS.BO is less volatile compared to INOXINDIA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check INOXINDIA.NS's competition here
DIACABS.BO vs JYOTICNC.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, JYOTICNC.NS has a market cap of 136B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while JYOTICNC.NS trades at ₹598.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas JYOTICNC.NS's P/E ratio is 40.51. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to JYOTICNC.NS's ROE of +0.19%. Regarding short-term risk, DIACABS.BO is more volatile compared to JYOTICNC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check JYOTICNC.NS's competition here
DIACABS.BO vs KIRLOSBROS.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KIRLOSBROS.NS has a market cap of 129B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KIRLOSBROS.NS trades at ₹1,624.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KIRLOSBROS.NS's P/E ratio is 34.58. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KIRLOSBROS.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLOSBROS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLOSBROS.NS's competition here
DIACABS.BO vs KIRLOSBROS.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KIRLOSBROS.BO has a market cap of 128.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KIRLOSBROS.BO trades at ₹1,623.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KIRLOSBROS.BO's P/E ratio is 32.84. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KIRLOSBROS.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLOSBROS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLOSBROS.BO's competition here
DIACABS.BO vs INGERRAND.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, INGERRAND.BO has a market cap of 121.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while INGERRAND.BO trades at ₹3,862.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas INGERRAND.BO's P/E ratio is 46.11. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to INGERRAND.BO's ROE of +0.41%. Regarding short-term risk, DIACABS.BO is more volatile compared to INGERRAND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check INGERRAND.BO's competition here
DIACABS.BO vs INGERRAND.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, INGERRAND.NS has a market cap of 121.7B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while INGERRAND.NS trades at ₹3,855.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas INGERRAND.NS's P/E ratio is 47.43. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to INGERRAND.NS's ROE of +0.41%. Regarding short-term risk, DIACABS.BO is more volatile compared to INGERRAND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check INGERRAND.NS's competition here
DIACABS.BO vs ELECON.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ELECON.BO has a market cap of 113.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ELECON.BO trades at ₹506.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ELECON.BO's P/E ratio is 33.37. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ELECON.BO's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is more volatile compared to ELECON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ELECON.BO's competition here
DIACABS.BO vs ELECON.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ELECON.NS has a market cap of 113.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ELECON.NS trades at ₹506.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ELECON.NS's P/E ratio is 33.28. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ELECON.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is more volatile compared to ELECON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ELECON.NS's competition here
DIACABS.BO vs KIRLPNU.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KIRLPNU.BO has a market cap of 103.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KIRLPNU.BO trades at ₹1,598.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KIRLPNU.BO's P/E ratio is 40.51. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KIRLPNU.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLPNU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLPNU.BO's competition here
DIACABS.BO vs KIRLPNU.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KIRLPNU.NS has a market cap of 103.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KIRLPNU.NS trades at ₹1,598.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KIRLPNU.NS's P/E ratio is 40.50. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KIRLPNU.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLPNU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLPNU.NS's competition here
DIACABS.BO vs DIACABS.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, DIACABS.NS has a market cap of 101.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while DIACABS.NS trades at ₹192.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas DIACABS.NS's P/E ratio is 64.23. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DIACABS.NS's ROE of -0.21%. Regarding short-term risk, DIACABS.BO is less volatile compared to DIACABS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check DIACABS.NS's competition here
DIACABS.BO vs VESUVIUS.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, VESUVIUS.NS has a market cap of 96.7B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while VESUVIUS.NS trades at ₹476.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas VESUVIUS.NS's P/E ratio is 37.07. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to VESUVIUS.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to VESUVIUS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VESUVIUS.NS's competition here
DIACABS.BO vs VESUVIUS.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, VESUVIUS.BO has a market cap of 96.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while VESUVIUS.BO trades at ₹475.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas VESUVIUS.BO's P/E ratio is 37.01. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to VESUVIUS.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to VESUVIUS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VESUVIUS.BO's competition here
DIACABS.BO vs LLOYDSENGG.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, LLOYDSENGG.NS has a market cap of 96.1B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while LLOYDSENGG.NS trades at ₹71.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas LLOYDSENGG.NS's P/E ratio is 47.99. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to LLOYDSENGG.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to LLOYDSENGG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LLOYDSENGG.NS's competition here
DIACABS.BO vs LLOYDSENGG.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, LLOYDSENGG.BO has a market cap of 95.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while LLOYDSENGG.BO trades at ₹71.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas LLOYDSENGG.BO's P/E ratio is 47.85. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to LLOYDSENGG.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to LLOYDSENGG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LLOYDSENGG.BO's competition here
DIACABS.BO vs ISGEC.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ISGEC.BO has a market cap of 67.7B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ISGEC.BO trades at ₹920.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ISGEC.BO's P/E ratio is 62.06. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ISGEC.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to ISGEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ISGEC.BO's competition here
DIACABS.BO vs ISGEC.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ISGEC.NS has a market cap of 67.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ISGEC.NS trades at ₹919.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ISGEC.NS's P/E ratio is 61.96. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ISGEC.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to ISGEC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ISGEC.NS's competition here
DIACABS.BO vs SHAKTIPUMP.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, SHAKTIPUMP.NS has a market cap of 65.7B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while SHAKTIPUMP.NS trades at ₹532.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas SHAKTIPUMP.NS's P/E ratio is 25.34. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SHAKTIPUMP.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is less volatile compared to SHAKTIPUMP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check SHAKTIPUMP.NS's competition here
DIACABS.BO vs SHAKTIPUMP.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, SHAKTIPUMP.BO has a market cap of 65.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while SHAKTIPUMP.BO trades at ₹532.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas SHAKTIPUMP.BO's P/E ratio is 25.35. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SHAKTIPUMP.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is less volatile compared to SHAKTIPUMP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check SHAKTIPUMP.BO's competition here
DIACABS.BO vs DIAPOWER.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, DIAPOWER.NS has a market cap of 52.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while DIAPOWER.NS trades at ₹195.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas DIAPOWER.NS's P/E ratio is -1.78. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DIAPOWER.NS's ROE of +0.05%. Regarding short-term risk, DIACABS.BO is less volatile compared to DIAPOWER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check DIAPOWER.NS's competition here
DIACABS.BO vs LSIL.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, LSIL.NS has a market cap of 52.1B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while LSIL.NS trades at ₹48.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas LSIL.NS's P/E ratio is 130.41. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to LSIL.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to LSIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LSIL.NS's competition here
DIACABS.BO vs TEXRAIL.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, TEXRAIL.BO has a market cap of 42.7B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while TEXRAIL.BO trades at ₹104.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas TEXRAIL.BO's P/E ratio is 21.67. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TEXRAIL.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to TEXRAIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TEXRAIL.BO's competition here
DIACABS.BO vs TEXRAIL.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, TEXRAIL.NS has a market cap of 42.7B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while TEXRAIL.NS trades at ₹104.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas TEXRAIL.NS's P/E ratio is 21.67. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TEXRAIL.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to TEXRAIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TEXRAIL.NS's competition here
DIACABS.BO vs GREAVESCOT.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, GREAVESCOT.NS has a market cap of 42.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while GREAVESCOT.NS trades at ₹182.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas GREAVESCOT.NS's P/E ratio is 40.13. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GREAVESCOT.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to GREAVESCOT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GREAVESCOT.NS's competition here
DIACABS.BO vs GREAVESCOT.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, GREAVESCOT.BO has a market cap of 42.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while GREAVESCOT.BO trades at ₹182.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas GREAVESCOT.BO's P/E ratio is 41.08. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GREAVESCOT.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to GREAVESCOT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GREAVESCOT.BO's competition here
DIACABS.BO vs WPIL.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, WPIL.BO has a market cap of 41.3B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while WPIL.BO trades at ₹423.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas WPIL.BO's P/E ratio is 26.17. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to WPIL.BO's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to WPIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check WPIL.BO's competition here
DIACABS.BO vs ANUP.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ANUP.BO has a market cap of 38.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ANUP.BO trades at ₹1,916.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ANUP.BO's P/E ratio is 34.89. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ANUP.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to ANUP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ANUP.BO's competition here
DIACABS.BO vs ANUP.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ANUP.NS has a market cap of 38.3B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ANUP.NS trades at ₹1,911.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ANUP.NS's P/E ratio is 34.73. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ANUP.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to ANUP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ANUP.NS's competition here
DIACABS.BO vs GMMPFAUDLR.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, GMMPFAUDLR.NS has a market cap of 35.1B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while GMMPFAUDLR.NS trades at ₹781.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas GMMPFAUDLR.NS's P/E ratio is 60.64. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GMMPFAUDLR.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is more volatile compared to GMMPFAUDLR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GMMPFAUDLR.NS's competition here
DIACABS.BO vs GMMPFAUDLR.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, GMMPFAUDLR.BO has a market cap of 35.1B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while GMMPFAUDLR.BO trades at ₹781.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas GMMPFAUDLR.BO's P/E ratio is 60.65. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GMMPFAUDLR.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to GMMPFAUDLR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GMMPFAUDLR.BO's competition here
DIACABS.BO vs SHANTIGEAR.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, SHANTIGEAR.NS has a market cap of 33.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while SHANTIGEAR.NS trades at ₹441.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas SHANTIGEAR.NS's P/E ratio is 44.14. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SHANTIGEAR.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to SHANTIGEAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SHANTIGEAR.NS's competition here
DIACABS.BO vs SHANTIGEAR.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, SHANTIGEAR.BO has a market cap of 33.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while SHANTIGEAR.BO trades at ₹440.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas SHANTIGEAR.BO's P/E ratio is 44.18. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SHANTIGEAR.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to SHANTIGEAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SHANTIGEAR.BO's competition here
DIACABS.BO vs SETL.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, SETL.NS has a market cap of 27.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while SETL.NS trades at ₹137.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas SETL.NS's P/E ratio is 34.26. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SETL.NS's ROE of +0.08%. Regarding short-term risk, DIACABS.BO is more volatile compared to SETL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SETL.NS's competition here
DIACABS.BO vs SGLTL.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, SGLTL.NS has a market cap of 27.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while SGLTL.NS trades at ₹137.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas SGLTL.NS's P/E ratio is 38.46. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SGLTL.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to SGLTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SGLTL.NS's competition here
DIACABS.BO vs HLEGLAS.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, HLEGLAS.NS has a market cap of 26.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while HLEGLAS.NS trades at ₹387.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas HLEGLAS.NS's P/E ratio is 53.75. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HLEGLAS.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is less volatile compared to HLEGLAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check HLEGLAS.NS's competition here
DIACABS.BO vs HLEGLAS.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, HLEGLAS.BO has a market cap of 26.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while HLEGLAS.BO trades at ₹387.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas HLEGLAS.BO's P/E ratio is 53.75. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HLEGLAS.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to HLEGLAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HLEGLAS.BO's competition here
DIACABS.BO vs JASH.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, JASH.NS has a market cap of 26.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while JASH.NS trades at ₹426.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas JASH.NS's P/E ratio is 35.54. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to JASH.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to JASH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check JASH.NS's competition here
DIACABS.BO vs WINDMACHIN.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, WINDMACHIN.BO has a market cap of 25.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while WINDMACHIN.BO trades at ₹283.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas WINDMACHIN.BO's P/E ratio is 3545.62. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to WINDMACHIN.BO's ROE of -0.00%. Regarding short-term risk, DIACABS.BO is more volatile compared to WINDMACHIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check WINDMACHIN.BO's competition here
DIACABS.BO vs WINDMACHIN.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, WINDMACHIN.NS has a market cap of 25.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while WINDMACHIN.NS trades at ₹283.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas WINDMACHIN.NS's P/E ratio is 3545.62. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to WINDMACHIN.NS's ROE of -0.00%. Regarding short-term risk, DIACABS.BO is more volatile compared to WINDMACHIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check WINDMACHIN.NS's competition here
DIACABS.BO vs KLBRENG-B.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KLBRENG-B.BO has a market cap of 25.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KLBRENG-B.BO trades at ₹488.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KLBRENG-B.BO's P/E ratio is 25.70. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KLBRENG-B.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to KLBRENG-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KLBRENG-B.BO's competition here
DIACABS.BO vs ADVAIT.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ADVAIT.BO has a market cap of 24.2B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ADVAIT.BO trades at ₹2,212.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ADVAIT.BO's P/E ratio is 46.81. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ADVAIT.BO's ROE of +0.23%. Regarding short-term risk, DIACABS.BO is less volatile compared to ADVAIT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check ADVAIT.BO's competition here
DIACABS.BO vs HONDAPOWER.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, HONDAPOWER.NS has a market cap of 23.7B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while HONDAPOWER.NS trades at ₹2,331.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas HONDAPOWER.NS's P/E ratio is 36.80. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HONDAPOWER.NS's ROE of +0.08%. Regarding short-term risk, DIACABS.BO is more volatile compared to HONDAPOWER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HONDAPOWER.NS's competition here
DIACABS.BO vs HONDAPOWER.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, HONDAPOWER.BO has a market cap of 23.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while HONDAPOWER.BO trades at ₹2,330.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas HONDAPOWER.BO's P/E ratio is 36.85. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HONDAPOWER.BO's ROE of +0.08%. Regarding short-term risk, DIACABS.BO is more volatile compared to HONDAPOWER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HONDAPOWER.BO's competition here
DIACABS.BO vs JNKINDIA.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, JNKINDIA.NS has a market cap of 23.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while JNKINDIA.NS trades at ₹421.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas JNKINDIA.NS's P/E ratio is 36.47. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to JNKINDIA.NS's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is less volatile compared to JNKINDIA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check JNKINDIA.NS's competition here
DIACABS.BO vs KMEW.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, KMEW.BO has a market cap of 23.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while KMEW.BO trades at ₹1,914.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas KMEW.BO's P/E ratio is 55.36. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KMEW.BO's ROE of +0.25%. Regarding short-term risk, DIACABS.BO is less volatile compared to KMEW.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check KMEW.BO's competition here
DIACABS.BO vs GMM.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, GMM.BO has a market cap of 22.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while GMM.BO trades at ₹1,563.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas GMM.BO's P/E ratio is 31.46. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GMM.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to GMM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GMM.BO's competition here
DIACABS.BO vs NIBE.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, NIBE.BO has a market cap of 22.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while NIBE.BO trades at ₹1,503.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas NIBE.BO's P/E ratio is 443.55. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to NIBE.BO's ROE of +0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to NIBE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check NIBE.BO's competition here
DIACABS.BO vs NIBE.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, NIBE.NS has a market cap of 22.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while NIBE.NS trades at ₹1,501.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas NIBE.NS's P/E ratio is 455.03. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to NIBE.NS's ROE of +0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to NIBE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check NIBE.NS's competition here
DIACABS.BO vs PIXTRANS.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, PIXTRANS.NS has a market cap of 21.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while PIXTRANS.NS trades at ₹1,606.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas PIXTRANS.NS's P/E ratio is 20.04. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to PIXTRANS.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to PIXTRANS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PIXTRANS.NS's competition here
DIACABS.BO vs PIXTRANS.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, PIXTRANS.BO has a market cap of 21.9B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while PIXTRANS.BO trades at ₹1,604.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas PIXTRANS.BO's P/E ratio is 20.00. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to PIXTRANS.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to PIXTRANS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PIXTRANS.BO's competition here
DIACABS.BO vs PENIND.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, PENIND.NS has a market cap of 21.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while PENIND.NS trades at ₹159.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas PENIND.NS's P/E ratio is 15.56. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to PENIND.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is less volatile compared to PENIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check PENIND.NS's competition here
DIACABS.BO vs PENIND.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, PENIND.BO has a market cap of 21.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while PENIND.BO trades at ₹159.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas PENIND.BO's P/E ratio is 15.52. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to PENIND.BO's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to PENIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PENIND.BO's competition here
DIACABS.BO vs ADOR.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ADOR.BO has a market cap of 19.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ADOR.BO trades at ₹1,120.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ADOR.BO's P/E ratio is 23.84. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ADOR.BO's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is more volatile compared to ADOR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ADOR.BO's competition here
DIACABS.BO vs ADOR.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ADOR.NS has a market cap of 19.5B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ADOR.NS trades at ₹1,119.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ADOR.NS's P/E ratio is 23.82. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ADOR.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is more volatile compared to ADOR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ADOR.NS's competition here
DIACABS.BO vs THEJO.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, THEJO.NS has a market cap of 17B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while THEJO.NS trades at ₹1,565.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas THEJO.NS's P/E ratio is 34.45. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to THEJO.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is less volatile compared to THEJO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check THEJO.NS's competition here
DIACABS.BO vs LXMIATO.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, LXMIATO.BO has a market cap of 16.6B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while LXMIATO.BO trades at ₹2,483.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas LXMIATO.BO's P/E ratio is 584.15. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to LXMIATO.BO's ROE of +0.01%. Regarding short-term risk, DIACABS.BO is less volatile compared to LXMIATO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check LXMIATO.BO's competition here
DIACABS.BO vs JYOTISTRUC.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, JYOTISTRUC.NS has a market cap of 16.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while JYOTISTRUC.NS trades at ₹13.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas JYOTISTRUC.NS's P/E ratio is 29.17. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to JYOTISTRUC.NS's ROE of +0.11%. Regarding short-term risk, DIACABS.BO is less volatile compared to JYOTISTRUC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check JYOTISTRUC.NS's competition here
DIACABS.BO vs JYOTISTRUC.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, JYOTISTRUC.BO has a market cap of 16.4B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while JYOTISTRUC.BO trades at ₹13.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas JYOTISTRUC.BO's P/E ratio is 30.47. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to JYOTISTRUC.BO's ROE of +0.11%. Regarding short-term risk, DIACABS.BO is less volatile compared to JYOTISTRUC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check JYOTISTRUC.BO's competition here
DIACABS.BO vs DISAQ.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, DISAQ.BO has a market cap of 16.3B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while DISAQ.BO trades at ₹11,221.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas DISAQ.BO's P/E ratio is 30.44. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DISAQ.BO's ROE of +0.19%. Regarding short-term risk, DIACABS.BO is more volatile compared to DISAQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check DISAQ.BO's competition here
DIACABS.BO vs ADORWELD.NS Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ADORWELD.NS has a market cap of 14.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ADORWELD.NS trades at ₹852.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ADORWELD.NS's P/E ratio is 33.22. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ADORWELD.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to ADORWELD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ADORWELD.NS's competition here
DIACABS.BO vs ADORWELD.BO Comparison June 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 101.6B. In comparison, ADORWELD.BO has a market cap of 14.8B. Regarding current trading prices, DIACABS.BO is priced at ₹192.75, while ADORWELD.BO trades at ₹852.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of 64.25, whereas ADORWELD.BO's P/E ratio is 24.67. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ADORWELD.BO's ROE of +0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to ADORWELD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ADORWELD.BO's competition here